Cancer Incidence and Mortality in Asian Countries: A Trend Analysis

Abstract

Background This study aimed to evaluate the updated burden and temporal trends of cancer incidence and mortality in Asian countries. Methodology The data used in this study were retrieved from the Global Cancer Observatory, Cancer Incidence in Five Continents volumes I-XI, and the World Health Organization mortality database. These data were used to calculate the Average Annual Percentage Change (AAPC), with a 95% confidence interval (CI) by joinpoint regression analysis to determine the epidemiological trend in the past decade. Results In 2020, the cancer incidence in Asia was 169.1 per 1 00 000, accounting for 49.3% of the global cancer incidence. The most common cancers included lung (13.8%), breast (10.8%) and colorectal (10.6%) cancers. Its mortality was 101.6 per 1 00 000 (58.3% of the global cancer death) with lung (19.2%), liver (10.5%) and stomach (9.9%) cancers being the most common causes of cancer death. The cancer incidence had been increasing in female population, with Korea (AAPC = 5.73, 95% CI [5.30, 6.17], P < .001), Japan (AAPC = 2.67, 95% CI [2.12, 3.23], P < .001) and Kuwait (AAPC = 2.08, 95% CI [.49, 3.69], P = .016) showing the most significant increases in the past decade. The incidence increase was also observed among population aged <40 years old, with Korea (female AAPC = 8.42, 95% CI [7.40, 9.45], P < .001; male AAPC = 5.28, 95% CI [4.23, 6.33], P <.001), China (female AAPC = 2.94, 95% CI [2.07, 3.81], P < .001; male AAPC = 1.37, 95% CI [.57, 2.18], P = .004) and Japan (female AAPC = 2.88, 95% CI [1.88, 3.88], P = .016; male AAPC = 1.59, 95% CI [.40, 2.78], P = .015) showing the most significant increases. However, there was an overall decreasing trend of cancer mortality. Conclusions There was a substantial burden of cancer incidence and mortality in Asia. Although there was a decreasing trend in cancer mortality, its incidence had been increasing especially among female and younger populations. Future studies could be done to further investigate the potential reasons for these epidemiologic trends.

Recent trends in the incidence and survival of stage I liver cancer: a surveillance, epidemiology, and end results analysis

“…According to our findings, the age-adjusted incidence rate of liver cancer increased from 2004 to 2015, and the incidence of stage I cases was significantly higher than other stages ( Figures 1 and 2 ). Since this significant amount of change was particular for stage I and occurred in a short period of time, it is unlikely to be the result of biological factors.…”

“…Liver cancer is one of the most frequent fatal malignancies worldwide [ 1 ] causing 830 000 deaths in 2020 [ 2 ]. The incidence of liver cancer demonstrates an increasing trend in developed countries and remains the eighth most common malignancy in women and fifth in men [ 3 ].…”

A Review of Interventions to Improve Medication Adherence of Patients with Chronic Diseases in Asia

“…According to the study of Claros, Messa, and Perdomo (2019), the number of cancer-related deaths is expected to increase annually from 14 million in 2012 to 22 million after two decades [16]. In 2020, a study have shown that lung cancer is the most commonly diagnosed cancer in Asia, with 13.8% cases, breast cancer comes second, with 10.8% cases, followed by colon cancer with 10.6% cases, stomach cancer with 8.6% cases and lastly liver cancer with 6.9% cases [17]. Men are more likely to develop lung, stomach, liver, colon/rectum, and esophageal cancers, while women are more likely to develop breast, lung, stomach, colon/rectum, and liver cancers [18].…”

“…Men are more likely to develop lung, stomach, liver, colon/rectum, and esophageal cancers, while women are more likely to develop breast, lung, stomach, colon/rectum, and liver cancers [18]. Moreover, a study of Huang et al (2022) also stated that the increase in urbanization, westernization, globalization, and common lifestyle habits, such as smoking, high-cholesterol foods, and alcohol consumption, are contributing factors to the burden of cancer in different countries of Asia [17]. According to Sankaranarayanan et al (2014) the emerging cases of this chronic disease requires utmost recognition, particularly from the government as it is also considered an important public health problem in Asia [18].…”

The Use of a Non-Invasive Biomarker for Colorectal Cancer Screening: A Comparative Cost-Effectiveness Modeling Study

“…The overall prevalence rates of adenoma (23.9%; 95% CI, 22.2-25.8%), advanced adenoma (4.6%; 95% CI, 3.8-5.5%), and CRC (0.4%, 95% CI, 0.3-0.5%) remain high worldwide [2]. Over the past decade, there has been an increasing trend of CRC incidence in Asian countries, which necessitates more intensive preventive initiatives [3]. CRC screening by fecal immunochemical tests (FITs) and colonoscopy has reduced CRC-related mortality by 33% and 68%, respectively [4][5][6].…”